June 2022 Vol 13, No 6

On behalf of all of us at the Academy of Oncology Nurse & Patient Navigators (AONN+) and the Journal of Oncology Navigation & Survivorship (JONS), I’d like to personally invite you to submit an abstract for the 13th Annual Navigation & Survivorship Conference to be held in New Orleans, LA, November 2-6, 2022. This is an opportunity to share your evidence-based navigation research studies, quality improvement projects, and best practices utilizing pre- and postdata elements to enhance your program with your navigation and survivorship care colleagues.
As a little girl, Tamika Felder dreamed of being on TV. She loved watching the news even at a very young age, had an unwavering curiosity about what was going on in the world, and set her sights on a career in television, which she later achieved. What she didn’t set her sights on was a cervical cancer diagnosis at the age of 25, a radical hysterectomy, and the devastating complete loss of her fertility.
The National Navigation Acuity Team – a collaborative initiative between AONN+ and Astellas – is developing an acuity tool to optimize patient care.
The line drawn between germline and somatic testing has grown very blurry, according to Leigha Senter-Jamieson, MS, CGC, cancer genetic counselor at The Ohio State University (OSU) in Columbus. Although similarities between the 2 types of testing do exist, it is important for navigators to be clear on the differences when it comes to educating patients and empowering them to be engaged in conversations about their own findings.
To remedy the systemic, institutional-level racism inherent in healthcare systems, navigators and other providers must actually work with those affected communities to determine barriers, appropriate outcome measures, and real-time interventions, according to Sam Cykert, MD, professor of medicine at the University of North Carolina.
The benefits of oncology navigation have been demonstrated in countless malignancies, and for many patients and providers it is now difficult to imagine a world without oncology navigators.
At its core, fertility preservation in patients with cancer is a survivorship issue, according to Megan Solinger, MHS, MA, OPN-CG, director of patient navigation at the Ulman Foundation.
With a much better understanding of the biology of cancer and other diseases, genetic medicine is entering “a whole new ballgame,” said Scott Gottlieb, MD, former director of the FDA, in a keynote address.

Results 1 - 9 of 9

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
    Profession or Role
    Primary Specialty or Disease State

    Please enter your mailing address.

    Address Line 2
    Zip Code